Cannabis and cancer: everything you need to know

By |2023-02-04T03:39:44+00:004 February 2023|

From palliative pain management to the side-effects of chemotherapy, cannabis can support cancer patients in significant ways. Some studies even suggest that cannabis could help treat, and possibly prevent, certain types of the disease. Here’s what the science says. The statistics sound scary: one in two [...]

Comments Off on Cannabis and cancer: everything you need to know

Study: could cannabis help close the ‘orgasm gap’?

By |2023-02-04T03:39:36+00:004 February 2023|

Cannabis appears to increase sex drive and satisfaction, and may help close the gender gap when it comes to sexual pleasure, say those behind a new study.  Researchers at East Carolina University and North Carolina State University in the US have suggested that cannabis could help [...]

Comments Off on Study: could cannabis help close the ‘orgasm gap’?

Cannabis and ovarian cancer: continuing Michelle Kendall’s legacy

By |2023-02-04T03:39:17+00:004 February 2023|

A recent study found promising effects of cannabis in the treatment of ovarian cancer, offering a glimmer of hope to women across the globe. Cannabis Health spoke to Bruce Kendall and Professor Hinanit Koltai about the remarkable story – and woman – behind it.  Michelle Kendall [...]

Comments Off on Cannabis and ovarian cancer: continuing Michelle Kendall’s legacy

How are consumers using CBD? 7 key trends in Europe

By |2023-02-03T03:06:37+00:003 February 2023|

A new report offers a hopeful picture of the current and future CBD landscape in Europe. We explore how, when, and why (or why not) people are using CBD products. CBD-infused products are popping up everywhere, from your local grocers to the high street pharmacy. The [...]

Comments Off on How are consumers using CBD? 7 key trends in Europe

New platform gives doctors tools to prescribe cannabis outside of specialist clinics

By |2023-02-03T03:06:18+00:003 February 2023|

A new online platform has been designed to overcome some of the issues preventing wider access to medical cannabis in the UK, by enabling doctors to prescribe independently of clinics.  Script Assist, which has been developed by the team at cannabis healthcare company, Sana Healthcare, aims [...]

Comments Off on New platform gives doctors tools to prescribe cannabis outside of specialist clinics

Malta’s cannabis club model to launch end of February – what you need to know

By |2023-02-03T03:06:01+00:003 February 2023|

Authorities in Malta have announced the details of its cannabis social club model, which is due to launch at the end of the month. Here’s everything you need to know. After an initial delay following the landmark legalisation of adult-use cannabis in 2021, the Maltese Authority [...]

Comments Off on Malta’s cannabis club model to launch end of February – what you need to know

Cannabis associated with long-term reduction in opioid use – study

By |2023-02-02T03:13:04+00:002 February 2023|

Medicinal cannabis was associated with a reduction in daily use of prescription opioids among chronic pain patients. A new study suggests that medical cannabis products were associated with substantial long-term decreases in the daily use of prescription opioids among patients living with chronic pain. With opioid-related [...]

Comments Off on Cannabis associated with long-term reduction in opioid use – study

NICE recommends Epidyolex for treatment of tuberous sclerosis complex

By |2023-02-02T03:12:39+00:002 February 2023|

The CBD-based drug, Epidyolex, will now be prescribed through the NHS for the treatment of seizures related to tuberous sclerosis complex (TSC). From 1 March 2023, patients living with TSC will have access to the cannabinoid-based treatment, Epidyolex, through the NHS, following a new recommendation from [...]

Comments Off on NICE recommends Epidyolex for treatment of tuberous sclerosis complex

Transparency for cannabis pilot trials in Switzerland

By |2023-01-31T03:54:21+00:0031 January 2023|

For the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the country’s Weed Care study within the Swiss pilot projects will be able to purchase cannabis in pharmacies in Basel.  The Swiss company Vigia AG has developed the Cannabis [...]

Comments Off on Transparency for cannabis pilot trials in Switzerland

Legalising cannabis does not increase substance misuse, finds study

By |2023-01-31T03:54:09+00:0031 January 2023|

New research refutes the theory that cannabis is a ‘gateway drug’, finding no increase in substance use disorders or psychological problems in states which have legalised adult-use.  The research from CU Boulder in the US, found that the legalisation of adult-use cannabis at the state level [...]

Comments Off on Legalising cannabis does not increase substance misuse, finds study

Four of the best CBD flower and tea brands

By |2023-01-28T03:09:26+00:0028 January 2023|

CBD flower exists in a regulatory grey area across Europe, but for many people it is their preferred method of cannabinoid consumption, whether vaporised or steeped in water and drank as tea. CBD has kind of outdone every other cannabinoid in the cannabis plant, in terms [...]

Comments Off on Four of the best CBD flower and tea brands

Satanic herbs and royal medicine: a (brief) history of cannabis in the UK

By |2023-01-28T03:09:07+00:0028 January 2023|

Whether for fibre, food or medicine, cannabis has been a part of life for thousands of years. The stigma around it, however, is relatively new. Read on for an overview of the history of cannabis in the UK. Humans and cannabis have had a symbiotic relationship [...]

Comments Off on Satanic herbs and royal medicine: a (brief) history of cannabis in the UK

Cannabis policy and psychosis – study finds no increase in rates of diagnosis

By |2023-01-27T03:41:41+00:0027 January 2023|

A new study has found no significant increase in the rates of psychosis-related diagnoses in states which have introduced cannabis policies. Researchers from the Hospital of the University of Pennsylvania in Philadelphia found no ‘statistically significant difference’ in the rates of psychosis-related diagnoses, or prescribed antipsychotics, [...]

Comments Off on Cannabis policy and psychosis – study finds no increase in rates of diagnosis

Czech Republic to outline laws for legalisation of adult-use cannabis

By |2023-01-27T03:41:30+00:0027 January 2023|

Proposals for the legalisation of adult-use cannabis in the Czech Republic are expected to be published in a matter of months with a focus on ‘reform, regulation and taxation’.  Draft laws, which would see the introduction of a regulated cannabis market in the Czech Republic, could [...]

Comments Off on Czech Republic to outline laws for legalisation of adult-use cannabis

The Grocer Awards recognise CBD Patches by BRITISH CANNABIS™

By |2023-01-26T03:04:08+00:0026 January 2023|

The Grocer Awards 2022 included CBD by BRITISH CANNABIS Dermal Patches as one of the ‘New Products of The Year’. The Rising New Product was selected to join a shortlist of finalists in the Personal Care Category at the annual event at the Hilton Bankside, London, [...]

Comments Off on The Grocer Awards recognise CBD Patches by BRITISH CANNABIS™

NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case

By |2023-01-26T03:03:47+00:0026 January 2023|

The NHS has reimbursed the cost of a UK patient’s private medicinal cannabis treatment, in what has been described as a ‘rare’ case.  A patient at Zerenia Clinics has successfully attained full reimbursement of the costs of unlicensed cannabis-based medication and clinic fees through the NHS.  [...]

Comments Off on NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case

Could medical cannabis play a role in treating substance misuse?

By |2023-01-25T03:25:02+00:0025 January 2023|

Dr Nat Wright, clinical advisor to European cannabis company AltoVerde, discusses how cannabis can play an important role in treating substance misuse and in alleviating the over-prescription of opioids. Medical cannabis became legal in the UK in 2018 and in the four years since, the number [...]

Comments Off on Could medical cannabis play a role in treating substance misuse?

Cannabis shows promise as treatment for borderline personality disorder (BPD)

By |2023-01-25T03:24:40+00:0025 January 2023|

The first research of its kind has reported ‘promising’ findings in the treatment of borderline personality disorder (BPD) with cannabinoids.  When used in a controlled clinical environment, cannabis-based medicines can lead to a ‘substantial improvement’ in symptoms associated with BPD, also known as emotionally unstable personality [...]

Comments Off on Cannabis shows promise as treatment for borderline personality disorder (BPD)

ACCESS CBD voted UK’s best CBD oil in pharmacy sector for sleep, stress and insomnia

By |2023-01-24T03:14:02+00:0024 January 2023|

BRITISH CANNABIS brand ACCESS CBD® was voted Best CBD Oil in Pharmacy for the second time, with CBD by BRITISH CANNABIS CBD Oils and Dermal Patches shortlisted for a further three categories.  The MVP Pharmacy Awards took place in November 2022 at a prestigious London venue [...]

Comments Off on ACCESS CBD voted UK’s best CBD oil in pharmacy sector for sleep, stress and insomnia

Access to adult-use cannabis reduced demand for prescription codeine – study

By |2023-01-24T03:13:38+00:0024 January 2023|

US states which have legalised adult-use cannabis have seen a reduction in demand for prescription codeine, according to a new study.  Published this week in Health Economics, a multi-institutional study led by University of Pittsburgh and Cornell University scientists, finds a significant reduction in pharmacy-based codeine [...]

Comments Off on Access to adult-use cannabis reduced demand for prescription codeine – study

One in five taking part in Dry January turn to cannabis instead – survey

By |2023-01-22T04:30:45+00:0022 January 2023|

One in five people taking part in Dry January are substituting alcohol for cannabis, a new survey from the US shows.  Dry January has become increasingly popular in recent years, as consumers attempt to ditch the drink throughout the first month of the year, following the [...]

Comments Off on One in five taking part in Dry January turn to cannabis instead – survey

UK patient registry to continue for fourth year with key changes

By |2023-01-22T04:30:14+00:0022 January 2023|

Drug Science has announced that its cannabis patient registry, Project Twenty21, will continue collecting data for a fourth year with new partners on board. The UK charity for drug reform confirmed this week that its medicinal cannabis patient registry, formerly known as Project Twenty21, will continue [...]

Comments Off on UK patient registry to continue for fourth year with key changes

Cruelty-free CBD: cannabis-based beauty products that are vegan-friendly

By |2023-01-20T03:02:30+00:0020 January 2023|

Whether you’re vegan-for-life or celebrating Veganuary, we’ve sought out some CBD-based beauty products that can help give you a cruelty-free cannabis glow-up. The start of a new year often goes hand in hand with resolutions, new routines and dreams of rejuvenation. It also happens to align [...]

Comments Off on Cruelty-free CBD: cannabis-based beauty products that are vegan-friendly

Linnea SA to produce medicinal cannabis in Switzerland 

By |2023-01-20T03:02:15+00:0020 January 2023|

Pharmaceutical manufacturer, Linnea SA, has been granted a licence for the production of high-THC medicinal cannabis products in Switzerland. Linnea SA was granted a narcotics licence by Swissmedic at the end of 2022, making it one of the first companies in Switzerland to be able to [...]

Comments Off on Linnea SA to produce medicinal cannabis in Switzerland 

Cost analysis of cannabis on the NHS to launch next month

By |2023-01-20T03:01:55+00:0020 January 2023|

A new project, designed to show how cannabis would be cost-effective on the NHS, is due to get underway next month. Experts at York Health Economics Consortium are to develop a flexible health economics analysis tool to evaluate the feasibility of prescribing cannabis on the NHS.  [...]

Comments Off on Cost analysis of cannabis on the NHS to launch next month

Bedrocan to manufacture cannabis products in Denmark

By |2023-01-19T03:04:43+00:0019 January 2023|

The Dutch producer of medicinal cannabis is to open a new facility in Denmark in order to meet demand from patients across Europe.  Bedrocan, the sole producer of medicinal cannabis in the Netherlands since 2003, has announced it will establish a new facility to manufacture its [...]

Comments Off on Bedrocan to manufacture cannabis products in Denmark

Dr Sandra Carrillo: exploring medicinal cannabis in Colombia

By |2023-01-19T03:04:05+00:0019 January 2023|

The Colombian government recently confirmed that cannabis medicines would be covered by the healthcare system, making it one of the few countries in the world to introduce such a policy.  Dr Sandra Carrillo, of the Colombian Medical Cannabis Association, tells Cannabis Health how attitudes are finally [...]

Comments Off on Dr Sandra Carrillo: exploring medicinal cannabis in Colombia

Regular cannabis consumption has no negative impact on public health – study

By |2023-01-18T03:05:58+00:0018 January 2023|

A new study from researchers in Spain found no decline in the health of regular cannabis consumers when compared to the general population. The paper, published in the journal Cannabis and Cannabinoid Research, assessed the impact of regular cannabis consumption on public health and compared the [...]

Comments Off on Regular cannabis consumption has no negative impact on public health – study

Over 89,000 private cannabis prescriptions since 2018, fewer than five on the NHS

By |2023-01-18T03:05:26+00:0018 January 2023|

The legalisation of cannabis on prescription has failed to deliver access for all, say advocates, as new figures reveal the growing gap between private and NHS prescribing.   New data has revealed the number of private and NHS cannabis prescriptions issued in England since the law change [...]

Comments Off on Over 89,000 private cannabis prescriptions since 2018, fewer than five on the NHS

Can cannabis help your mental health? Everything you need to know

By |2023-01-17T03:42:37+00:0017 January 2023|

With the prevalence of poor mental health on the rise, many people are finding cannabis helpful for managing symptoms of common disorders such as depression, anxiety and PTSD. We explore its role in mental health treatment in more detail.  All of us have ‘mental health’ – [...]

Comments Off on Can cannabis help your mental health? Everything you need to know

UK Medical Cannabis Registry – what does the latest data say?

By |2023-01-17T03:41:59+00:0017 January 2023|

Three new research studies have been published using data from the UK Medical Cannabis Registry that demonstrate the effects of cannabis in those living with depression, childhood epilepsy and inflammatory bowel disease (IBD). The Registry, which is run by Sapphire Medical Clinics, is thought to be [...]

Comments Off on UK Medical Cannabis Registry – what does the latest data say?

Nature’s medicine: could cannabis be key in the fight for climate and biodiversity?

By |2023-01-14T03:04:00+00:0014 January 2023|

After decades of negotiations, almost 200 countries have agreed to a historic deal to halt and reverse biodiversity loss by 2030. Cannabis could help get them to the goal while slashing carbon emissions in the process. Planetary health is human health, and the twin challenges of [...]

Comments Off on Nature’s medicine: could cannabis be key in the fight for climate and biodiversity?

Latest cannabis research: five new studies to know about

By |2023-01-13T03:16:54+00:0013 January 2023|

In recent weeks, promising research has been published on the potential of cannabis as a tool for sleep, muscle recovery, multiple sclerosis (MS) and inflammatory bowel disease (IBD). With a record number of research papers published on cannabis and its therapeutic potential in 2022, it can [...]

Comments Off on Latest cannabis research: five new studies to know about

UK company granted approval for clinical trial of synthetic CBD on sleep

By |2023-01-13T03:16:19+00:0013 January 2023|

UK company, Chanelle McCoy Health, has been granted ethics approval in Australia for a clinical trial investigating the effect of its synthetic CBD formulation on sleep. The pharmaceutical company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia, for a significant Phase III [...]

Comments Off on UK company granted approval for clinical trial of synthetic CBD on sleep

US study finds rise in cannabis-related hospital visits among older people

By |2023-01-12T03:10:38+00:0012 January 2023|

New findings highlighting a rise in cannabis-related hospital visits among older consumers have led to calls for more patient-doctor communication around its use in medical care.  As a growing number of older adults are experimenting with cannabis to help alleviate chronic symptoms, a new study has [...]

Comments Off on US study finds rise in cannabis-related hospital visits among older people

Cannabis and pregnancy: what the latest research says

By |2023-01-12T03:09:59+00:0012 January 2023|

The short- and long-term effects of prenatal cannabis use on both parent and child are still poorly understood. New research from North America sheds light on this sensitive topic.  Some people consume cannabis during pregnancy to alleviate symptoms such as nausea, stress, insomnia, and pain (to [...]

Comments Off on Cannabis and pregnancy: what the latest research says

How does THC work in the body? Researchers share new scientific insights

By |2023-01-11T03:20:19+00:0011 January 2023|

A new study provides fresh insights into how THC interacts with the human body to provide therapeutic effects.  In various European countries and North America, cannabis-based medicines are authorised for therapeutic purposes.  While the cannabis plant contains over 100 cannabinoids, THC (D9-tetrahydrocannabinol) and CBD (cannabidiol) are [...]

Comments Off on How does THC work in the body? Researchers share new scientific insights

Medicinal cannabis in Spain: inside the country’s first ‘cannabis clinic’

By |2023-01-11T03:19:25+00:0011 January 2023|

With draft regulations for the legalisation of medicinal cannabis in Spain expected imminently, we explore the existing grey market and meet those bridging the gap to help patients access the treatment safely. Last year the Spanish government took a significant step towards legalising medicinal cannabis for [...]

Comments Off on Medicinal cannabis in Spain: inside the country’s first ‘cannabis clinic’

Nearly one third of people with chronic pain turn to cannabis – study

By |2023-01-10T03:22:50+00:0010 January 2023|

Almost a third of patients with chronic pain reported using cannabis to manage it, according to new findings from the US.  As more US states legalise cannabis for medical and recreational use, increasing numbers of people are experimenting with it for pain relief, a new study [...]

Comments Off on Nearly one third of people with chronic pain turn to cannabis – study

First US guidance published on cannabis use in surgery patients

By |2023-01-10T03:22:15+00:0010 January 2023|

All patients undergoing a procedure requiring anaesthesia should be screened for cannabis use, according to new guidance published in the US. The first guidelines on cannabis use in relation to surgery have been issued by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain [...]

Comments Off on First US guidance published on cannabis use in surgery patients

Dry January: how cannabis can help cure the holiday hangover

By |2023-01-07T03:01:55+00:007 January 2023|

The holidays can be a boozy blur of celebratory bevvies and festive cheer. But an almost month-long drinking binge can result in a hangover of whole-body proportions. Could cannabis help drink-lovers take a break from the tipple this Dry January?  Whether it’s sparkling wine at the [...]

Comments Off on Dry January: how cannabis can help cure the holiday hangover

France overturns ban on sale of CBD flower – what you need to know

By |2023-01-07T03:01:35+00:007 January 2023|

Regulators in France have reversed a ban on the sale and consumption of CBD flower. We’ve summarised everything you need to know.  As of Thursday, 29 December 2022, the French Council of State (Conseil d’État) overturned a decision to cancel the ban on the sale and [...]

Comments Off on France overturns ban on sale of CBD flower – what you need to know

Many Dispenseroo customers buying cannabis for medical reasons, says founder

By |2023-01-06T03:48:40+00:006 January 2023|

Illegal UK cannabis startup, Dispenseroo, has revealed that many customers are using its products to treat medical conditions. What does its so-called success say about the current state of play? The founder of the online dispensary – who goes by the name of ‘S’ – claims [...]

Comments Off on Many Dispenseroo customers buying cannabis for medical reasons, says founder

10 cannabis trends to watch out for in 2023

By |2023-01-05T03:16:31+00:005 January 2023|

Will 2023 be the year we see some major shifts in access and attitudes towards cannabis? With help from experts, we lay out our predictions for the year ahead.  2022 saw some major developments for cannabis across the globe. The collective value of the CBD, medical [...]

Comments Off on 10 cannabis trends to watch out for in 2023

Scientific research on cannabis reached new heights in 2022

By |2023-01-04T03:13:18+00:004 January 2023|

Cannabis research continues to flourish across the globe, with a record number of scientific papers published in 2022.  Hundreds more studies were published on cannabis in 2022 than in the years previously, according to figures collected by the US advocacy group NORML. Campaigners for wider access [...]

Comments Off on Scientific research on cannabis reached new heights in 2022

Cannabis year-in-review: 22 takeaways from 2022

By |2022-12-28T03:27:46+00:0028 December 2022|

This year saw some exciting developments for cannabis across Europe, but the UK’s medical cannabis system must do more to support patients.  In 2022 new research showed promising potential for cannabis to treat pain, depression, Covid-19 and even Alzheimer’s; Germany announced plans to legalise adult-use cannabis; [...]

Comments Off on Cannabis year-in-review: 22 takeaways from 2022

Cannabis can reduce liver damage caused by alcohol – study

By |2022-12-24T03:26:33+00:0024 December 2022|

Could cannabis help mitigate some of the liver damage caused by excessive alcohol consumption? A recent study suggests so.   Cannabis is often touted as a less harmful alternative to alcohol. However, a new study has found that the compounds found in the plant may actually reduce [...]

Comments Off on Cannabis can reduce liver damage caused by alcohol – study

Cole’s ‘Christmas wish’ for year’s supply of cannabis oil comes true

By |2022-12-23T03:05:39+00:0023 December 2022|

A Scottish mum says she has been ‘blown away’ by the support of donors who helped raise £18,000 to fund her son’s medication for a year.  Thirty six business owners in Lanarkshire, Scotland have pledged £500 to help cover the costs of medical cannabis treatment for [...]

Comments Off on Cole’s ‘Christmas wish’ for year’s supply of cannabis oil comes true

Zerenia Clinics celebrates first year of operation in the UK

By |2022-12-22T03:33:31+00:0022 December 2022|

Zerenia Clinics UK recently marked its first anniversary, having helped over 500 patients to access potentially life-changing cannabis medicine. At the end of November, Zerenia Clinics UK celebrated its first year of operation in the UK.  In its initial year, Zerenia Clinics UK is proud to [...]

Comments Off on Zerenia Clinics celebrates first year of operation in the UK

Government review to explore barriers to research on controlled drugs

By |2022-12-22T03:33:25+00:0022 December 2022|

The UK government has called for a review to address some of the barriers currently holding back research into controlled drugs, including synthetic cannabinoids.  Home Office officials have acknowledged that the current regulations may be holding back research into Schedule 1 drugs, including synthetic cannabinoids (SCRAs). [...]

Comments Off on Government review to explore barriers to research on controlled drugs